| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DPO-1 | 43077-30-1 | sc-203570 sc-203570A | 10 mg 50 mg | $170.00 $715.00 | ||
DPO-1 is a potent KV1.5 inhibitor characterized by its ability to selectively disrupt potassium ion conduction through the channel. Its unique molecular structure facilitates specific interactions with the channel's inner vestibule, leading to a conformational change that hinders ion passage. The compound exhibits rapid kinetics, allowing for swift modulation of channel activity. Furthermore, DPO-1's hydrophobic regions enhance its membrane permeability, optimizing its interaction with lipid bilayers. | ||||||
Ibutilide Fumarate | 122647-32-9 | sc-211627 | 10 mg | $250.00 | ||
Ibutilide is a class III antiarrhythmic agent that activates KV1.5 channels, leading to delayed repolarization. It is used for atrial fibrillation and atrial flutter. | ||||||
Apremilast | 608141-41-9 | sc-480062 | 5 mg | $444.00 | ||
Apremilast is an agent in research used for certain autoimmune diseases like psoriasis and psoriatic arthritis. While its primary mechanism of action is related to immune modulation, it has been found to have some effects on KV1.5 channels. | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $52.00 $86.00 | 6 | |
Ibuprofen, a common nonsteroidal anti-inflammatory drug (NSAID), has been shown to inhibit KV1.5 channels to some extent. This property is of interest in understanding potential off-target effects of NSAIDs. | ||||||